We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
For investors seeking momentum, VanEck Vectors Israel ETF (ISRA - Free Report) is probably on the radar now. The fund just hit a 52-week high and is up nearly 18.8% from its 52-week low price of $28.13/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
ISRA in Focus
The fund tracks the BlueStar Israel Global Index which comprises of equity securities, which may include depositary receipts, of publicly traded companies that are generally considered by the Index Provider to be Israeli companies. Information Technology accounts for 36.1% of the fund, followed by Health Care (22.2%). Israel accounts for around 72.4% of the fund while United States (24.5%) takes the next position. The product charges 59 bps in fees (see all World ETFs here).
Why the Move?
Investors should note that there have been several positive happenings in the Israel economy of late. In early August, the Tel Aviv Stock Exchange touched a three-year high on Standard & Poor’s upgrade of Israel’s credit rating. Plus, there is news that the Israeli Securities Authority has permitted the sale of a majority stake in the Tel Aviv Stock Exchange to a group of foreign investors in order to make it a publicly traded company. All these factors probably have given the fund a boost.
More Gains Ahead?
The fund has a Zacks Rank #3 (Hold). Plus, it seems that the fund will perform decently in the near term given a positive weighted alpha of 18.50.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Israel ETF (ISRA) Hits New 52-Week High
For investors seeking momentum, VanEck Vectors Israel ETF (ISRA - Free Report) is probably on the radar now. The fund just hit a 52-week high and is up nearly 18.8% from its 52-week low price of $28.13/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
ISRA in Focus
The fund tracks the BlueStar Israel Global Index which comprises of equity securities, which may include depositary receipts, of publicly traded companies that are generally considered by the Index Provider to be Israeli companies. Information Technology accounts for 36.1% of the fund, followed by Health Care (22.2%). Israel accounts for around 72.4% of the fund while United States (24.5%) takes the next position. The product charges 59 bps in fees (see all World ETFs here).
Why the Move?
Investors should note that there have been several positive happenings in the Israel economy of late. In early August, the Tel Aviv Stock Exchange touched a three-year high on Standard & Poor’s upgrade of Israel’s credit rating. Plus, there is news that the Israeli Securities Authority has permitted the sale of a majority stake in the Tel Aviv Stock Exchange to a group of foreign investors in order to make it a publicly traded company. All these factors probably have given the fund a boost.
More Gains Ahead?
The fund has a Zacks Rank #3 (Hold). Plus, it seems that the fund will perform decently in the near term given a positive weighted alpha of 18.50.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>